ILUSTRO: A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer (clinicaltrials.gov) - Sep 1, 2026 - P2 | N=143 | Active, not recruiting | Sponsor: Astellas Pharma Global Development, Inc. | Trial completion date: Nov 2027 ➔ May 2028 | Trial primary completion date: Dec 2026 ➔ Jun 2027
Monotherapy • Trial completion date • Trial primary completion date • Esophageal Cancer • Gastric Cancer • Gastroesophageal Cancer • Gastroesophageal Junction Adenocarcinoma • Oncology • Solid Tumor • CLDN18
|